A legal challenge has been filed at the Federal High Court, Abuja that may force a national reckoning over how far Nigeria will allow foreign partners to handle sensitive health information.
The originating summons was lodged this week by Okpi Bernard Adaafu. It names the Federal Government of Nigeria and other senior state actors. The summons asks the court to determine whether a bilateral Memorandum of Understanding with the United States unlawfully exposes Nigerians’ medical and genetic data.
National Assembly of Nigeria is also criticised in the papers for being excluded from prior scrutiny.
This is not a narrow privacy complaint. The suit alleges the MOU was signed on 19 December 2025. It permits the collection and cross-border transfer of highly sensitive material such as medical records, blood samples, pathogen testing results, and DNA or genetic sequencing data. These arrangements, the plaintiff says, could bind Nigeria for decades.
The MoU’s published summary promises strengthened disease surveillance and laboratory cooperation. However, parts of the underlying arrangements remain undisclosed to the public. This is according to court filings and copies of an internal specimen sharing annex obtained by observers.
Adaafu’s central legal argument is straightforward. He argues that the agreement and an accompanying Specimen Sharing Agreement would breach the National Health Act 2014. It would also violate the Nigeria Data Protection Act 2023. This is because it permits transfers and processing of personal and genetic data without proper legal basis. There is no oversight or parliamentary approval.
He also invokes Section 37 of the 1999 Constitution to argue that the deal violates the guaranteed right to privacy.
The papers further claim the specimen sharing terms could require Nigeria to surrender biological samples and related data within five days of request and that operational commitments may persist for as long as 25 years.
The timing of the lawsuit intensifies its political stakes. Implementation of the programme is scheduled to begin on 1 April 2026, according to government communications and the MoU summary.
Opposition voices and civil society groups have already pressed Abuja for full publication of the agreements and for assurances that data transfers will meet Nigeria’s data adequacy and safeguarding standards.
The federal Ministry of Health’s public statement frames the MoU as designed to strengthen outbreak response, laboratory systems and primary care, while promising technical assistance and financing.
Critics say summary language on support and investment cannot substitute for transparent legal and parliamentary scrutiny of provisions that implicate citizens’ bodily integrity and national sovereignty.
Religious neutrality and social cohesion are other fault lines in the suit. Adaafu highlights statements suggesting targeted support for Christian faith-based health institutions under the programme.
He argues that introducing or appearing to privilege religious affiliation in a national health cooperation framework risks constitutional and social problems in a multi-faith nation.
The claim demands a judicial clarification of whether international health assistance can be administered in ways that favour identifiable religious groups, and whether such emphasis was contemplated or authorised by the executive when the MoU was signed.
The US Department of State press notice describing aspects of the cooperation has drawn particular attention from the plaintiff and analysts.
Another legal axis concerns the role of the legislature. Adaafu faults the executive for not subjecting the agreement to legislative scrutiny and approval.
Under Nigeria’s constitutional arrangements, treaties and agreements that have significant domestic implications typically require parliamentary oversight and, in some cases, ratification.
The suit asks the court to declare that international agreements with major implications for national resources, sovereignty or citizens’ rights require the involvement of the National Assembly before they take effect.
This element of the claim turns the case into an institutional test of separation of powers as much as a privacy litigation.
What remedies does the plaintiff seek? The originating summons asks the court to suspend implementation of the MoU pending final determination, declare that the specimen sharing and data transfer arrangements breach the National Health Act 2014 and the Nigeria Data Protection Act 2023, and issue a prohibition against discriminatory programmes based on religion, ethnicity or other protected characteristics.
If granted, those orders would halt planned transfers and compel full disclosure and legislative engagement before any programme activity commences.
For policymakers the case poses hard choices. Advocates of the MoU argue that international technical cooperation, if properly governed, can substantially strengthen Nigeria’s surveillance capacity and laboratory networks, marshal financing, and reduce the human cost of outbreaks.
Skeptics reply that cooperation under poorly transparent terms risks data extraction, undermines trust in the health system, and may unlock commercial or scientific uses of Nigerian genetic resources without adequate benefit sharing or consent.
The longer-term concern is reputational: Nigerians may resist public health measures if they fear medical data are not protected.
What happens next. The Federal High Court will first consider interlocutory applications. The executive may seek to strike out the suit or argue that national security and international cooperation considerations justify the MoU.
Civil society groups and data protection experts are likely to seek leave to intervene. Whatever the procedural moves, the litigation advances an unavoidable public debate about modern public health practice, individual rights, and the limits of international partnerships.
As Adaafu put it in his explanatory note, the potential implications for the privacy, sovereignty and constitutional rights of more than 200 million Nigerians “deserve public awareness and national discourse.”
The court’s handling of the case will test how Nigerian law balances urgent public health aims with robust legal safeguards for citizens’ most intimate information.
- WhatsApp: https://whatsapp.com/channel/0029VawZ8TbDDmFT1a1Syg46
- Telegram: https://t.me/atlanticpostchannel
- Facebook: https://www.messenger.com/channel/atlanticpostng
